These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Conversion of free fatty acids to triglycerides. Determination in obstructive vs hepatocellular jaundice, and cirrhosis. Santos M; Friedberg SJ; Kudzma DJ; Tjoa LT Arch Intern Med; 1974 Sep; 134(3):457-60. PubMed ID: 4851179 [No Abstract] [Full Text] [Related]
5. [Hepatic glycuroconjugation function explored by the salicilate test in viral hepatitis, in cholestatic jaundice and in hepatic cirrhosis]. Diversi D Epatologia; 1966; 12(1):37-51. PubMed ID: 6004486 [No Abstract] [Full Text] [Related]
7. On the clinical use of the 131I-triolein test. Corsini G; Gandolfi E Nucl Med (Stuttg); 1967; ():57-66. PubMed ID: 5601758 [No Abstract] [Full Text] [Related]
8. Assessment of body-iron stores in cirrhosis and haemochromatosis with the differential ferrioxamine test. Smith PM; Studley F; Williams R Lancet; 1967 Jan; 1(7482):133-6. PubMed ID: 4163312 [No Abstract] [Full Text] [Related]
9. [THE SIGNIFICANCE OF SERUM IRON CONTENT AND IRON-BINDING PROTEIN IN THE DIFFERENTIAL DIAGNOSIS OF VARIOUS DISEASES]. BRUESCHKE G; HERRMANN H; ISRAEL S Z Arztl Fortbild (Jena); 1964 Feb; 58():142-6. PubMed ID: 14151714 [No Abstract] [Full Text] [Related]
10. [Properdin system and liver diseases]. Reissmann G Z Gesamte Inn Med; 1970 Apr; 25(7):297-300. PubMed ID: 5521440 [No Abstract] [Full Text] [Related]
11. ABSORPTION OF IRON IN CIRRHOSIS OF LIVER. CALLENDER ST; MALPAS JS Br Med J; 1963 Dec; 2(5371):1516-8. PubMed ID: 14063081 [No Abstract] [Full Text] [Related]
12. IRON ABSORPTION IN LIVER DISEASE. MALPAS JS; CALLENDER ST Sangre (Barc); 1964; 17():246-8. PubMed ID: 14218357 [No Abstract] [Full Text] [Related]
13. Influence of alcohol on iron absorption from the digestive tract. Brodanová M; Kordac V Rev Czech Med; 1970; 16(4):183-96. PubMed ID: 5491482 [No Abstract] [Full Text] [Related]
14. STUDIES IN IRON ABSORPTION. III. BODY RADIOACTIVITY MEASUREMENTS OF PATIENTS WITH LIVER DISEASE. GREENBERG MS; STROHMEYER G; HINE GJ; KEENE WR; CURTIS G; CHALMERS TC Gastroenterology; 1964 Jun; 46():651-61. PubMed ID: 14173923 [No Abstract] [Full Text] [Related]
15. Cholic acid clearance in normal subjects and in patients with liver disease. Borel GA; Lemp R; Diallo T; Magnenat P Helv Med Acta; 1973 Sep; 37(2):201-7. PubMed ID: 4748930 [No Abstract] [Full Text] [Related]
16. Studies on iron absorption in acute liver disease. Brown H; Callender ST; Malpas JS Br Med J; 1968 Mar; 1(5595):799-801. PubMed ID: 5641485 [No Abstract] [Full Text] [Related]
17. [Significance in the determination of total and free phenols in acute hepatitis and liver cirrhosis]. Davcev P; Hrisoho R; Vanovski B; Popstefanova A; Bidikov V God Zb Med Fak Skopje; 1974; 20():59-72. PubMed ID: 4465266 [No Abstract] [Full Text] [Related]
18. Metabolic differences between hepatitis and cholestasis in human liver. Scherstén T Prog Liver Dis; 1972; 4():133-50. PubMed ID: 4568995 [No Abstract] [Full Text] [Related]
19. [Fecal excretion of lipids and bile acids in obstructive icterus and acute virus hepatitis]. Erb W; Kröhl R; Schreiber J; Wildgrube J Z Gastroenterol; 1972; 10(2):85-96. PubMed ID: 4671767 [No Abstract] [Full Text] [Related]